ANAB
AnaptysBio, Inc.
There isn't enough reported data to score ANAB yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
ANAB Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Strong |
ANAB's balance sheet is currently strong, but its profitability is under pressure. There isn't enough data to rate its revenue and cash flow.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
ANAB PE Valuation
ANAB has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 5.3x next year's earnings.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
ANAB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ANAB to return to profit, with revenue growing. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
ANAB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.01 | — |
| Q1 2026 | -$1.02 | +$3.74 |
| Q4 2025 | -$0.46 | +$4.66 |
| Q3 2025 | -$2.73 | +$3.35 |
| Q2 2025 | -$4.39 | +$1.96 |
| Q1 2025 | -$4.76 | +$1.38 |
| Q4 2024 | -$5.12 | +$0.96 |
| Q3 2024 | -$6.08 | -$0.66 |
| Q2 2024 | -$6.35 | -$1.16 |
UNH has the stronger earnings trend. Trailing diluted EPS is down 121% for ANAB versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
ANAB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30.3M | -60% |
| Q1 2026 | $25.6M | -8% |
| Q4 2025 | $108.2M | +151% |
| Q3 2025 | $76.3M | +154% |
| Q2 2025 | $22.3M | +103% |
| Q1 2025 | $27.8M | +287% |
| Q4 2024 | $43.1M | +379% |
| Q3 2024 | $30M | +805% |
ANAB has the stronger quarterly revenue trend. Revenue is up 36% for ANAB versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +20 points |
| Q1 2026 | -136% | -36 points |
| Q4 2025 | 62% | +84 points |
| Q3 2025 | 45% | +121 points |
| Q2 2025 | -118% | +250 points |
| Q1 2025 | -99% | +489 points |
| Q4 2024 | -22% | +446 points |
| Q3 2024 | -76% | +1061 points |
ANAB has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
ANAB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$9.5M | +$17.8M |
| Q1 2026 | -$25.9M | -$15.2M |
| Q4 2025 | $98M | +$164.9M |
| Q3 2025 | -$27.4M | -$17.2M |
| Q2 2025 | -$40.3M | -$18.9M |
| Q1 2025 | -$10.7M | +$26.5M |
| Q4 2024 | -$66.9M | -$32.3M |
| Q3 2024 | -$10.1M | +$26.5M |
ANAB has the stronger cash trend. Its trailing FCF is up 149% versus its history, compared with UNH at up 5.2%.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
ANAB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +22% | +6.4M shares |
| 1 year | +22% | +6.3M shares |
| 3 years | +32% | +8.4M shares |
| 5 years | +28% | +7.7M shares |
| Available history | +30% | +8M shares |
ANAB has 35M diluted shares, up 22% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $3.4M |
| Q3 2025 | $9.7M |
| Q2 2025 | $51.1M |
| Q1 2025 | $4.4M |
| Q4 2024 | $456,000 |
| Q3 2024 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over ANAB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
ANAB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -6.0x | Net Cash |
| Q4 2025 | -4.9x | Net Cash |
| Q3 2021 | -40.6x | Net Cash |
ANAB has more cash than debt.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
ANAB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.4 | Neutral |
| Stochastic | 21.4 | Neutral |
ANAB's weekly RSI is 45 (neutral) and its Stochastic is 21 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
ANAB PE vs Healthcare Sector
| Metric | ANAB | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
ANAB has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
ANAB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.9 | 0.3% below |
| 20 week MA | $53.7 | 11% below |
| 50 week MA | $47.7 | 0.1% above |
| 100 week MA | $31.5 | 52% above |
| 200 week MA | $23.5 | 103% above |
ANAB has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 103% above its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over ANAB on trend strength, trading above more of its moving averages.
ANAB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.2 | $14.8 | +33% |
| 2021 | $14.8 | $24.7 | +67% |
| 2022 | $24.7 | $19.5 | -21% |
| 2023 | $19.5 | $14.3 | -27% |
| 2024 | $14.3 | $8.69 | -39% |
| 2025 | $8.69 | $33.4 | +284% |
| 2026 YTD | $33.4 | $47.8 | +43% |
ANAB has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.